Naoki Sasahira

8PUBLICATIONS
39CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)Regenerative medicine (incl. stem cells)Veterinary virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 01, 2026
Pharmacogenomic profiling of the efficacy of gemcitabine monotherapy in metastatic pancreatic cancer: Subgroup analysis of the GENESECT study.

|Jul 28, 2025
Modified Fluorouracil, Leucovorin, Irinotecan, and Oxaliplatin or S-1, Irinotecan, and Oxaliplatin Versus Nab-Paclitaxel + Gemcitabine in Metastatic or Recurrent Pancreatic Cancer (GENERATE, JCOG1611): A Randomized, Open-Label, Phase II/III Trial.

Akihiro Ohba, Masato Ozaka, Junki Mizusawa

|Apr 10, 2025
Pathological complete response following addition of durvalumab to gemcitabine and cisplatin therapy for intrahepatic cholangiocarcinoma with Lynch syndrome-associated mismatch repair deficiency.

Koshiro Fukuda, Akiyoshi Kasuga, Yasuyuki Shigematsu

|Aug 25, 2023
Safety and Effectiveness of Chemotherapy in Elderly Biliary Tract Cancer Patients.

Takeshi Okamoto, Tsuyoshi Takeda, Takashi Sasaki

|Jan 21, 2023
Treatment Outcomes and Prognostic Factors of Gemcitabine Plus Nab-Paclitaxel as Second-Line Chemotherapy after Modified FOLFIRINOX in Unresectable Pancreatic Cancer.

Takafumi Mie, Takashi Sasaki, Tsuyoshi Takeda

|Feb 16, 2021
A case of endoscopic ultrasound-guided hepaticogastrostomy for obstructive jaundice caused by intraductal papillary mucinous neoplasm-associated pancreatobiliary fistula.

Takafumi Mie, Takashi Sasaki, Tsuyoshi Takeda

Pageof 2

Frequent Collaborators

3 joint publications

Tsuyoshi Takeda

3 joint publications

Takashi Sasaki

3 joint publications

Takeshi Okamoto

3 joint publications

Akiyoshi Kasuga